- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7115 - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
Patent holdings for IPC class A61K 31/7115
Total number of patents in this class: 1135
10-year publication summary
58
|
68
|
88
|
91
|
111
|
102
|
119
|
136
|
102
|
52
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Modernatx, Inc. | 1260 |
130 |
Ionis Pharmaceuticals, Inc. | 859 |
56 |
Factor Bioscience Inc. | 99 |
36 |
Alnylam Pharmaceuticals, Inc. | 1146 |
21 |
The General Hospital Corporation | 4704 |
17 |
The Trustees of the University of Pennsylvania | 4308 |
16 |
Translate bio, Inc. | 414 |
16 |
BioNTech SE | 640 |
15 |
The Regents of the University of California | 19812 |
11 |
President and Fellows of Harvard College | 5949 |
11 |
Arrowhead Pharmaceuticals, Inc. | 292 |
11 |
Replicor Inc. | 25 |
11 |
University of Massachusetts | 2218 |
11 |
SomaLogic Operating Co., Inc. | 246 |
11 |
Moderna Therapeutics, Inc. | 70 |
10 |
Osaka University | 3362 |
10 |
TriLink Biotechnologies, LLC | 74 |
10 |
Aligos Therapeutics, Inc. | 148 |
10 |
The Board of Trustees of the Leland Stanford Junior University | 6365 |
9 |
Idera Pharmaceuticals, Inc. | 82 |
9 |
Other owners | 704 |